Iris Care Group has acquired Elysium Cymru to further expand its supported living provision. The acquisition includes two supported living services, The Grove and Kensington Place, both based in Newport, South Wales.
“This acquisition . . . demonstrates our strategic drive to build and deliver exceptional services, with strong reputations,...
ASX-listed Percheron Therapeutics, an international biotechnology company focused on developing novel therapies for oncology and rare diseases, has announced changes to the company’sexecutive leadership.
Dr Michael Baker has been appointed to the role of managing director and CEO, effective 5 October. He succeeds Dr James Garner, CEO and managing director since August 2023, who will step down to take up a new professional opportunity overseas. Garner will remain in his current position until 31 August.
Baker is an experienced biotech executive and public company CEO. His most recent role was as...